Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Rosella Centis

11 ta ish

Istituti Clinici Scientifici Maugeri

AkademScholarda batafsil koʻrsatkichlar

  1. Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

    Shama D. Ahuja, David Ashkin, Monika Avendano +70

    Sharh maqolaOchiq kirish20129 iqtibos
    ABI

  2. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

    Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori +11

    Sharh maqolaOchiq kirish20124 iqtibos
    ABI

  3. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

    Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82

    Sharh maqolaOchiq kirish20144 iqtibos
    ABI

  4. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

    Sharh maqolaOchiq kirish20184 iqtibos
    ABI

  5. Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis

    Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +18

    BoshqaOchiq kirish20163 iqtibos
    ABI

  6. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

    Giovanni Battista Migliori, Giovanni Sotgiu, Neel R. Gandhi +16

    Sharh maqolaOchiq kirish20122 iqtibos
    ABI

  7. WHO recommendations on shorter treatment of multidrug-resistant tuberculosis

    Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +3

    MaqolaOchiq kirish20162 iqtibos
    ABI

  8. Tuberculosis control in prisons: current situation and research gaps

    Masoud Dara, Colleen Acosta, Natalie V. S. Vinkeles Melchers +8

    Sharh maqolaOchiq kirish20152 iqtibos
    ABI

  9. Tuberculosis, social determinants and co-morbidities (including HIV)

    Raquel Duarte, Knut Lönnroth, Cláudia Carvalho +4

    Sharh maqolaOchiq kirish20172 iqtibos
    ABI

  10. Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

    Giovanni Sotgiu, Simon Tiberi, Rosella Centis +4

    Maqola20162 iqtibos
    ABI

  11. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

    Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

    Sharh maqolaOchiq kirishTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibos
    ABI